PHARMACOKINETICS OF (+)-1,2-DI(3,5-DIOXOPIPERAZIN-1-YL)PROPANE INTRAVENOUS INFUSIONS IN ADULT CANCER-PATIENTS

This publication has 8 references indexed in Scilit:

• PHASE-I TRIAL OF ICRF-187 BY 48-HOUR CONTINUOUS INFUSION
  1981
• PRE-CLINICAL TOXICOLOGIC EVALUATION OF ICRF-187 IN DOGS
  1980
• PHASE-II STUDY OF ICRF-159 IN NON-HODGKINS LYMPHOMAS
  1978
• ICRF-159: Current status and clinical prospects
  Published by Elsevier ,1977
• PHASE-2 STUDY OF DIANHYDROGALACTITOL AND ICRF-159 IN PATIENTS WITH ADVANCED BREAST-CANCER PREVIOUSLY EXPOSED TO CYTOTOXIC CHEMOTHERAPY
  1977
• PHASE-2 STUDY OF ICRF-159 IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA PREVIOUSLY EXPOSED TO SYSTEMIC CHEMOTHERAPY
  1976
• TREATMENT OF KAPOSIS SARCOMA WITH ICRF-159 (NSC-129943)
  1976
• A New Reagent for Detection of Peptides, Nucleotides, and Other N—H-containing Compounds on Paper Chromatograms
  Journal of Biological Chemistry, 1962